FSD Pharma Inc.
NASDAQ:HUGE
0.0899 (USD) • At close August 14, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | 2016 Q4 | 2016 Q3 | 2016 Q2 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.008 | 0 | 0.159 | 0.01 | 0.014 | 0.014 | 0.001 | 0.011 | 0.022 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of Revenue
| 0.12 | 0.126 | 0.145 | 1.122 | 1.13 | 1.159 | 1.082 | 1.123 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.579 | 0 | 1.164 | 0.742 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross Profit
| -0.12 | -0.126 | -0.145 | -1.122 | -1.13 | -1.159 | -1.082 | -1.123 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.571 | 0 | -1.005 | -0.733 | 0.014 | 0.014 | 0.001 | 0.011 | 0.022 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -68.216 | 0 | -6.314 | -75.76 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Reseach & Development Expenses
| 0.16 | -0.031 | -0.033 | 1.611 | 2.312 | 2.695 | 1.867 | 1.412 | 0.937 | 0.852 | -0.107 | 3.613 | 1.97 | 2.493 | 3.488 | 1.52 | 0.284 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 1.973 | 1.809 | 3.198 | 2.744 | 5.857 | 2.807 | 4.241 | 5.322 | 3.611 | 4.159 | 4.235 | 8.094 | 6.881 | 2.647 | 7.923 | 2.212 | 4.986 | 7.152 | 7.482 | 7.08 | 1.911 | 4.704 | 1.485 | 2.632 | 2.698 | 0.005 | 0.006 | 0.003 | 0.014 | 0.001 | 0.013 | 0.008 |
Selling & Marketing Expenses
| -0.009 | 0.161 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.885 | 0.33 | 0 | 0.799 | 1.144 | 0.707 | 0.002 | 0.002 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SG&A
| 1.964 | 1.97 | 3.198 | 2.744 | 5.857 | 2.807 | 4.241 | 5.322 | 3.611 | 4.159 | 4.235 | 8.094 | 6.881 | 2.647 | 7.923 | 2.212 | 4.986 | 5.266 | 7.813 | 7.08 | 2.709 | 5.848 | 2.192 | 2.634 | 2.701 | 0.005 | 0.006 | 0.003 | 0.014 | 0.001 | 0.013 | 0.008 |
Other Expenses
| 0 | 0 | 2.012 | 1.107 | 1.13 | 1.158 | 1.146 | 1.132 | 1.101 | 1.107 | 1.005 | 0.04 | 0.012 | 0.423 | 0.194 | 0.052 | 0.013 | 1.843 | 1.103 | -0.245 | 0.109 | -0.178 | -0.159 | 0 | 0.031 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Expenses
| 2.124 | 1.939 | 3.312 | 5.462 | 9.299 | 6.66 | 7.254 | 7.866 | 5.65 | 6.119 | 5.133 | 12.689 | 9.803 | 6.193 | 13.064 | 4.7 | 6.181 | 7.11 | 8.916 | 7.217 | 2.772 | 6.028 | 2.347 | 2.634 | 2.745 | 0.005 | 0.006 | 0.003 | 0.014 | 0.001 | 0.013 | 0.008 |
Operating Income
| -2.243 | -2.065 | -3.312 | -8.832 | -9.845 | -6.66 | -7.254 | -7.866 | -5.65 | -6.119 | -5.133 | -12.689 | -9.803 | -6.193 | -13.064 | -4.7 | -6.265 | -8.283 | -9.726 | -7.448 | -2.649 | 3.217 | -2.337 | -2.612 | -2.745 | -0.005 | -0.006 | -0.003 | -0.009 | -0.001 | -0.013 | -0.008 |
Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -561.787 | 0 | -52.03 | -1,005.468 | -528.517 | -191.215 | 4,107.423 | -218.245 | -116.966 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Other Income Expenses Net
| 0.161 | 0.368 | 2.006 | 3.341 | -0.113 | 0.511 | 0.125 | -0.1 | 0.189 | -0.015 | -0.48 | -0.046 | 0.416 | 2.093 | 0.808 | 0.946 | -1.398 | -6.554 | -2.852 | -3.643 | 1.038 | -9.244 | 5.322 | 5.703 | 0.031 | 0 | 0 | 0 | -0.005 | 0 | 0 | 0 |
Income Before Tax
| -2.082 | -1.697 | -1.131 | -5.49 | -9.958 | -6.148 | -7.129 | -7.966 | -5.461 | -6.163 | -5.615 | -12.754 | -9.406 | -4.134 | -12.316 | -3.821 | -7.648 | -14.744 | -12.578 | -10.851 | -1.721 | -15.271 | 2.985 | 3.09 | -2.714 | -0.005 | -0.006 | -0.003 | -0.014 | -0.001 | -0.013 | -0.008 |
Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -456.673 | 0 | -92.614 | -1,300.331 | -770.029 | -124.183 | -19,500.023 | 278.854 | 138.388 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Income Tax Expense
| -0.187 | -0 | -0.169 | 2.927 | 0.93 | -0.209 | -0.038 | -3.456 | 0.322 | 0.2 | 0.656 | 0.539 | 0.129 | -1.235 | 0.543 | -0.342 | 2.538 | 6.698 | 2.852 | 3.398 | -1.967 | 18.488 | -10.644 | -11.404 | -0.031 | 0 | 0 | 0 | 0.005 | 0 | 0 | 0 |
Net Income
| -1.895 | -1.697 | -1.131 | -8.417 | -10.888 | -5.94 | -7.091 | -4.51 | -5.783 | -6.348 | -5.791 | -13.207 | -9.939 | -4.569 | -13.473 | -4.372 | -8.775 | -14.744 | -12.578 | -10.851 | -1.721 | -15.271 | 2.985 | 3.09 | -2.714 | -0.005 | -0.006 | -0.003 | -0.014 | -0.001 | -0.013 | -0.008 |
Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -522.625 | 0 | -92.614 | -1,300.331 | -770.029 | -124.183 | -19,500.023 | 278.854 | 138.388 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS
| -0.048 | -0.043 | -0.029 | -0.21 | -0.28 | -0.15 | -0.19 | -0.12 | -0.14 | -0.18 | -0.16 | -0.37 | -0.37 | -0.36 | -1.06 | -0.48 | -1.08 | -2.19 | -1.66 | -1.55 | -0.25 | -2.32 | 0.46 | -0.61 | -0.41 | -0.001 | -0.001 | -0.001 | 0 | -0 | -0.002 | -0.001 |
EPS Diluted
| -0.048 | -0.043 | -0.029 | -0.21 | -0.28 | -0.15 | -0.19 | -0.12 | -0.14 | -0.18 | -0.16 | -0.37 | -0.37 | -0.36 | -1.06 | -0.48 | -1.08 | -2.19 | -1.66 | -1.55 | -0.25 | -2.32 | 0.39 | -0.61 | -0.41 | -0.001 | -0.001 | -0.001 | 0 | -0 | -0.002 | -0.001 |
EBITDA
| -2.124 | -1.939 | -3.159 | -1.242 | -7.897 | -5.203 | -6.005 | -6.731 | -4.466 | -5.012 | -4.128 | -11.668 | -8.84 | -4.782 | -11.871 | -3.68 | -5.258 | -6.903 | -8.519 | -7.271 | -3.652 | 3.275 | -7.626 | -8.315 | -2.701 | -0.005 | -0.006 | -0.003 | -0.014 | -0.001 | -0.013 | -0.008 |
EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -439.87 | 0 | -43.359 | -880.733 | -516.001 | -263.608 | 4,182.06 | -712.268 | -372.319 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |